Inhaled chemotherapy adverse effects: mechanisms and protection methods

Lung cancer is still diagnosed at a late stage due to a lack of symptoms. Although there are novel therapies, many patients are still treated with chemotherapy. In an effort to reduce adverse effects associated with chemotherapy, inhaled administration of platinum analogs has been investigated. Inha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lung cancer management 2020-01, Vol.8 (4), p.LMT19
Hauptverfasser: Sardeli, Chrysanthi, Zarogoulidis, Paul, Kosmidis, Christoforos, Amaniti, Aikaterini, Katsaounis, Athanasios, Giannakidis, Dimitrios, Koulouris, Charilaos, Hohenforst-Schmidt, Wolfgang, Huang, Haidong, Bai, Chong, Michalopoulos, Nikolaos, Tsakiridis, Kosmas, Romanidis, Konstantinos, Oikonomou, Panagoula, Mponiou, Konstantina, Vagionas, Anastasios, Goganau, Alexandru Marian, Kesisoglou, Isaak, Sapalidis, Konstantinos
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Lung cancer is still diagnosed at a late stage due to a lack of symptoms. Although there are novel therapies, many patients are still treated with chemotherapy. In an effort to reduce adverse effects associated with chemotherapy, inhaled administration of platinum analogs has been investigated. Inhaled administration is used as a local route in order to reduce the systemic adverse effects; however, this treatment modality has its own adverse effects. In this mini review, we present drugs that were administered as nebulized droplets or dry powder aerosols for non-small-cell lung cancer. We present the adverse effects and methods to overcome them.
ISSN:1758-1966
1758-1974
DOI:10.2217/lmt-2019-0007